| Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates EE Walsh, RW Frenck Jr, AR Falsey, N Kitchin, J Absalon, A Gurtman, ... New England Journal of Medicine 383 (25), 2439-2450, 2020 | 2672 | 2020 |
| Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure X Qian, HN Nguyen, MM Song, C Hadiono, SC Ogden, C Hammack, ... Cell 165 (5), 1238-1254, 2016 | 1969 | 2016 |
| COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... Nature 586 (7830), 594-599, 2020 | 1889 | 2020 |
| Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults MJ Mulligan, KE Lyke, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... Nature 586 (7830), 589-593, 2020 | 1733 | 2020 |
| Spike mutation D614G alters SARS-CoV-2 fitness JA Plante, Y Liu, J Liu, H Xia, BA Johnson, KG Lokugamage, X Zhang, ... Nature 592 (7852), 116-121, 2021 | 1659 | 2021 |
| 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members S Daffis, KJ Szretter, J Schriewer, J Li, S Youn, J Errett, TY Lin, ... Nature 468 (7322), 452-456, 2010 | 941 | 2010 |
| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 907 | 2021 |
| Evasion of type I interferon by SARS-CoV-2 H Xia, Z Cao, X Xie, X Zhang, JYC Chen, H Wang, VD Menachery, ... Cell reports 33 (1), 2020 | 861 | 2020 |
| Zika virus: History, emergence, biology, and prospects for control SC Weaver, F Costa, MA Garcia-Blanco, AI Ko, GS Ribeiro, G Saade, ... Antiviral research 130, 69-80, 2016 | 798 | 2016 |
| SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ... Nature 596 (7870), 109-113, 2021 | 682 | 2021 |
| BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... Nature 595 (7868), 572-577, 2021 | 644 | 2021 |
| Neutralizing activity of BNT162b2-elicited serum Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ... New England Journal of Medicine 384 (15), 1466-1468, 2021 | 642 | 2021 |
| Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ... Nature medicine 27 (4), 620-621, 2021 | 638 | 2021 |
| Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299, 2021 | 621 | 2021 |
| An infectious cDNA clone of SARS-CoV-2 X Xie, A Muruato, KG Lokugamage, K Narayanan, X Zhang, J Zou, J Liu, ... Cell host & microbe 27 (5), 841-848. e3, 2020 | 616 | 2020 |
| BNT162b vaccines protect rhesus macaques from SARS-CoV-2 AB Vogel, I Kanevsky, Y Che, KA Swanson, A Muik, M Vormehr, LM Kranz, ... Nature 592 (7853), 283-289, 2021 | 593 | 2021 |
| NS5 of dengue virus mediates STAT2 binding and degradation J Ashour, M Laurent-Rolle, PY Shi, A García-Sastre Journal of virology 83 (11), 5408-5418, 2009 | 551 | 2009 |
| A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity GP Pijlman, A Funk, N Kondratieva, J Leung, S Torres, L Van der Aa, ... Cell host & microbe 4 (6), 579-591, 2008 | 533 | 2008 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 528 | 2021 |
| A single mutation in the prM protein of Zika virus contributes to fetal microcephaly L Yuan, XY Huang, ZY Liu, F Zhang, XL Zhu, JY Yu, X Ji, YP Xu, G Li, C Li, ... Science 358 (6365), 933-936, 2017 | 491 | 2017 |
